Cargando…
Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma
Cholangiocarcinoma (CCA) has been identified as a highly malignant cancer that can be transformed from epithelial cells of the bile duct, including intrahepatic, perihilar and extrahepatic. High-resolution imaging tools (abdominal ultrasound, computed tomography and percutaneous transhepatic cholang...
Autores principales: | Chang, Yu-Chan, Chen, Ming-Huang, Yeh, Chun-Nan, Hsiao, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600697/ https://www.ncbi.nlm.nih.gov/pubmed/32998289 http://dx.doi.org/10.3390/biom10101377 |
Ejemplares similares
-
Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022) -
Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients
por: Yeh, Chun-Nan, et al.
Publicado: (2017) -
MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma
por: Chiang, Kun-Chun, et al.
Publicado: (2017) -
Current status of liver transplantation for cholangiocarcinoma
por: Twohig, Patrick, et al.
Publicado: (2022) -
Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
por: Tsai, Chun-Yi, et al.
Publicado: (2022)